Description

Vaccine technologies have garnered increased interest from pharmaceutical companies and biotech companies in the last few years. Not only are there companies working on newer vaccine types, but also on platform technologies for delivery, production, adjuvants and so on. This study is aimed at delivering an overview of the research portfolio for vaccines across different core segments and geographies. There is a marked difference in immunization programs and vaccine R&D across geographies, depending on country specific programs and funding, and the report delves into these aspects and discuses regional portfolio and regional business challenges.